C57BL/6JCya-Otub1em1/Cya
Common Name
Otub1-KO
Product ID
S-KO-00499
Backgroud
C57BL/6JCya
Strain ID
KOCMP-107260-Otub1-B6J-VA
When using this mouse strain in a publication, please cite “Otub1-KO Mouse (Catalog S-KO-00499) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Otub1-KO
Strain ID
KOCMP-107260-Otub1-B6J-VA
Gene Name
Product ID
S-KO-00499
Gene Alias
-
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
Chr 19
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000025679
NCBI RefSeq
NM_134150
Target Region
Exon 1~7
Size of Effective Region
~7.9 kb
Overview of Gene Research
Otub1, short for ovarian tumor domain-containing ubiquitin aldehyde-binding protein 1, is a crucial deubiquitinase within the OTU superfamily. It plays a significant role in multiple physiological processes, such as DNA damage repair, cytokines secretion, and regulating the stability of various proteins [4]. It is involved in pathways related to immune response, ferroptosis, and cell metabolism, and is of great biological importance in maintaining normal cellular functions. Genetic models, like gene knockout (KO) and conditional knockout (CKO) mouse models, are valuable for studying its functions.
Global and conditional osteoblast KO of Otub1 result in low bone mass and poor bone strength due to osteogenic differentiation and mineralization defects. Mechanistically, OTUB1 stabilizes FGFR2, a key osteogenesis regulator, by inhibiting SMURF1-mediated FGFR2 ubiquitination. AAV9-delivered FGFR2 rescued bone mass loss in osteoblast-specific Otub1-deleted mice, and restoring OTUB1 levels in osteoporotic mice alleviated osteopenia [1]. In gastric cancer, CST1 promotes metastasis by recruiting OTUB1 to relieve GPX4 ubiquitination, improving its stability and inhibiting ferroptosis [2]. In breast cancer, OTUB1 deubiquitinates MYC at K323, blocking its degradation, promoting HK2-mediated glycolysis, and tumorigenesis [3].
In conclusion, Otub1, through its deubiquitinase activity, plays essential roles in maintaining protein stability and regulating various biological processes. Studies using KO/CKO mouse models have revealed its significance in diseases like osteoporosis, gastric cancer, and breast cancer, providing potential therapeutic targets for these conditions.
References:
1. Zhu, Qiong, Fu, Yesheng, Cui, Chun-Ping, Liu, Cui Hua, Zhang, Lingqiang. 2023. OTUB1 promotes osteoblastic bone formation through stabilizing FGFR2. In Signal transduction and targeted therapy, 8, 142. doi:10.1038/s41392-023-01354-2. https://pubmed.ncbi.nlm.nih.gov/37024477/
2. Li, Dongbao, Wang, Yuhong, Dong, Chao, Hu, Lin, Zhou, Jin. 2022. CST1 inhibits ferroptosis and promotes gastric cancer metastasis by regulating GPX4 protein stability via OTUB1. In Oncogene, 42, 83-98. doi:10.1038/s41388-022-02537-x. https://pubmed.ncbi.nlm.nih.gov/36369321/
3. Han, Xue, Ren, Chune, Lu, Chao, Yang, Tingting, Yu, Zhenhai. 2022. Deubiquitination of MYC by OTUB1 contributes to HK2 mediated glycolysis and breast tumorigenesis. In Cell death and differentiation, 29, 1864-1873. doi:10.1038/s41418-022-00971-8. https://pubmed.ncbi.nlm.nih.gov/35296795/
4. Liao, Yihao, Yang, Mengyue, Wang, Keke, Zhong, Boqiang, Jiang, Ning. 2021. Deubiquitinating enzyme OTUB1 in immunity and cancer: Good player or bad actor? In Cancer letters, 526, 248-258. doi:10.1016/j.canlet.2021.12.002. https://pubmed.ncbi.nlm.nih.gov/34875341/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
